Tumor agnostic efficacy of selpercatinib in patients with RET fusion plus solid tumors: A global, multicenter, registrational trial update (LIBRETTO-001) Meeting Abstract


Authors: Subbiah, V.; Wolf, J.; Konda, B.; Kang, H.; Spira, A. I.; Weiss, J.; Takeda, M.; Ohe, Y.; Khan, S. A.; Ohashi, K.; Soldatenkova, V.; Szymczak, S.; Sullivan, L.; Wright, J.; Drilon, A. E.
Abstract Title: Tumor agnostic efficacy of selpercatinib in patients with RET fusion plus solid tumors: A global, multicenter, registrational trial update (LIBRETTO-001)
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680300987
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.3094
Notes: Meeting Abstract: 3094 -- Meeting also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon